BizStats
You are here: bizstats.co.uk > a-z index > C list > CY list > CYC list > CYCL list

Cyclacel Limited LONDON

Founded in 1996, Cyclacel, classified under reg no. 03237549 is an active company. Currently registered at 2 London Wall Place EC2Y 5AU, London the company has been in the business for twenty eight years. Its financial year was closed on 31st December and its latest financial statement was filed on Saturday 31st December 2022. Since Friday 25th October 1996 Cyclacel Limited is no longer carrying the name Ecdysis.

Currently there are 2 directors in the the company, namely Paul M. and Spiro R.. In addition one secretary - Paul M. - is with the firm. Currently there are several former directors listed by the company. In addition, the company lists several former secretaries. The full list of both former directors and former secretaries might be found in the box below.

Cyclacel Limited Address / Contact

Office Address 2 London Wall Place
Town London
Post code EC2Y 5AU
Country of origin United Kingdom

Company Information / Profile

Registration Number 03237549
Date of Incorporation Tue, 13th Aug 1996
Industry Research and experimental development on biotechnology
End of financial Year 31st December
Company age 28 years old
Account next due date Mon, 30th Sep 2024 (157 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Thu, 22nd Aug 2024 (2024-08-22)
Last confirmation statement dated Tue, 8th Aug 2023

Company staff

Paul M.

Position: Director

Appointed: 01 January 2002

Paul M.

Position: Secretary

Appointed: 01 January 2002

Spiro R.

Position: Director

Appointed: 12 August 1997

David U.

Position: Director

Appointed: 20 May 2004

Resigned: 30 June 2004

Daniel G.

Position: Director

Appointed: 17 July 2003

Resigned: 30 June 2004

Christopher E.

Position: Director

Appointed: 20 March 2003

Resigned: 30 June 2004

John B.

Position: Director

Appointed: 18 July 2002

Resigned: 30 June 2004

John M.

Position: Director

Appointed: 01 February 2002

Resigned: 30 June 2004

Parag S.

Position: Director

Appointed: 07 June 2001

Resigned: 30 June 2004

James D.

Position: Director

Appointed: 21 March 2001

Resigned: 31 January 2002

Robert J.

Position: Director

Appointed: 31 January 2001

Resigned: 30 June 2004

Hugh P.

Position: Secretary

Appointed: 23 November 2000

Resigned: 31 December 2001

Hugh P.

Position: Director

Appointed: 01 July 2000

Resigned: 21 March 2001

Howard M.

Position: Director

Appointed: 13 August 1999

Resigned: 25 May 2004

Jane F.

Position: Director

Appointed: 06 May 1999

Resigned: 17 July 2003

William S.

Position: Director

Appointed: 07 September 1998

Resigned: 25 May 2004

Bradley H.

Position: Secretary

Appointed: 12 February 1998

Resigned: 23 November 2000

Elizabeth H.

Position: Director

Appointed: 19 May 1997

Resigned: 06 May 1999

Peter K.

Position: Director

Appointed: 19 May 1997

Resigned: 20 March 2003

Mark R.

Position: Director

Appointed: 19 May 1997

Resigned: 05 June 2001

Roderick W.

Position: Secretary

Appointed: 10 September 1996

Resigned: 12 February 1998

Christopher E.

Position: Director

Appointed: 10 September 1996

Resigned: 21 May 2001

David G.

Position: Director

Appointed: 10 September 1996

Resigned: 10 September 1996

David L.

Position: Director

Appointed: 10 September 1996

Resigned: 30 June 2004

Fergus N.

Position: Director

Appointed: 10 September 1996

Resigned: 06 May 1997

Susan F.

Position: Director

Appointed: 09 September 1996

Resigned: 02 June 2000

Robert W.

Position: Nominee Director

Appointed: 13 August 1996

Resigned: 10 September 1996

Barbara R.

Position: Nominee Director

Appointed: 13 August 1996

Resigned: 10 September 1996

Mitre Secretaries Limited

Position: Corporate Nominee Secretary

Appointed: 13 August 1996

Resigned: 10 September 1996

Company previous names

Ecdysis October 25, 1996
Intercede 1190 September 10, 1996

Annual reports financial information

Profit & Loss
Accounts Information Date 2018-12-312019-12-312020-12-312021-12-312022-12-31
Balance Sheet
Cash Bank On Hand371 608517 5481 058 734646 861504 080
Current Assets1 902 3471 934 4702 410 0094 798 4377 649 925
Debtors1 530 7391 416 9221 351 2754 151 5767 145 845
Net Assets Liabilities-134 854 102-135 547 708-136 392 961-149 952 440-183 351 848
Other Debtors279 44746 93519 1431 283 5972 772 120
Property Plant Equipment25 98918 36076 66447 00526 827
Other
Audit Fees Expenses6 2306 4156 6006 9308 315
Accrued Liabilities Deferred Income1 183 363892 069856 8482 110 1023 608 310
Accumulated Depreciation Impairment Property Plant Equipment4 493 8364 194 688443 42258 92284 085
Additions Other Than Through Business Combinations Property Plant Equipment 6 55373 81119 9264 985
Administrative Expenses2 318 1592 194 4462 399 8353 054 5731 812 990
Average Number Employees During Period1315131515
Bank Borrowings30 761 70031 586 26932 449 65435 549 06542 388 727
Bank Borrowings Overdrafts133 445 152135 968 615137 566 628151 199 830185 360 973
Cash Cash Equivalents Cash Flow Value371 608517 5481 058 734646 861504 080
Corporation Tax Recoverable894 3041 005 7671 004 7952 758 4323 858 048
Creditors133 445 152135 968 615137 566 628151 199 830185 360 973
Deferred Income    7 655
Deferred Tax Expense Credit From Unrecognised Tax Loss Or Credit   45361
Depreciation Expense Property Plant Equipment 14 18214 50026 99025 163
Depreciation Impairment Expense Property Plant Equipment21 18214 18214 50026 99025 163
Distribution Costs3 324 6013 563 1683 685 32511 219 68716 636 826
Equity Settled Share-based Payments Increase Decrease In Equity248 310367 365334 176665 521642 582
Further Item Cash Flow From Used In Financing Activities Component Net Cash Flows From Used In Financing Activities -6 197 967-5 498 949-10 924 493-14 630 606
Further Item Current Tax Expense Credit Component Total Current Tax Expense-894 304-1 005 767-1 004 795-2 758 432-3 839 468
Further Item Tax Increase Decrease Component Adjusting Items277 542312 134311 833856 065-2 868 057
Future Minimum Lease Payments Under Non-cancellable Operating Leases1 734 9191 479 5771 224 235  
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss 82 0705 019 425  
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables 1 805 363218 917-2 285 046-2 061 920
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables -225 280-64 6751 046 6641 894 653
Gain Loss On Disposals Property Plant Equipment12 55027 945-1 007-22 595 
Gain On Financing Activities Due To Foreign Exchange Differences 4 722 6405 001 421  
Income Taxes Paid Refund Classified As Operating Activities888 950910 6521 005 7671 004 7952 739 852
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation -145 940-541 186411 873 
Increase Decrease In Current Tax Due To Changes In Accounting Policies Errors -16 348   
Increase Decrease In Current Tax From Adjustment For Prior Periods -16 348   
Increase From Depreciation Charge For Year Property Plant Equipment 14 18214 50026 99025 163
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings   46390
Interest Income On Bank Deposits7124   
Interest Paid To Group Undertakings968 3471 048 1361 100 4851 082 2651 348 053
Interest Payable Similar Charges Finance Costs8 441 7431 048 1361 100 4852 709 17219 530 627
Interest Received Classified As Investing Activities-71-24   
Net Cash Flows From Used In Financing Activities -6 197 967-5 498 949-10 924 493 
Net Cash Flows From Used In Investing Activities13 185-21 41673 81119 926 
Net Cash Flows From Used In Operating Activities4 096 1746 073 4434 883 95211 316 44014 768 402
Net Cash Generated From Operations 6 984 0955 889 71912 320 77217 508 164
Net Current Assets Liabilities-1 434 939402 5471 097 0031 200 3851 982 298
Net Finance Income Costs714 722 6645 001 421  
Net Interest Paid Received Classified As Operating Activities   -463-90
Number Equity Instruments Exercisable Share-based Payment Arrangement148 939668 27855 845238 489634 536
Number Equity Instruments Granted Share-based Payment Arrangement246 2721 419 020465 000514 169280 000
Number Equity Instruments Outstanding Share-based Payment Arrangement553 3621 691 301544 4551 003 2191 272 219
Operating Profit Loss-5 524 195-5 757 614-6 085 160-14 274 260-18 350 831
Other Creditors  61 964  
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment 313 3303 765 765411 490 
Other Disposals Property Plant Equipment 313 3303 766 772434 085 
Other Interest Expense7 473 396  1 626 44418 182 484
Other Interest Receivable Similar Income Finance Income714 722 6645 001 421  
Other Operating Income Format1118 565   98 985
Other Remaining Borrowings 104 382 346105 116 974115 650 765142 972 246
Other Taxation Social Security Payable38 60537 39929 39333 86239 409
Pension Other Post-employment Benefit Costs Other Pension Costs47 17261 21677 644102 348101 830
Prepayments Accrued Income356 988364 220327 337109 547489 046
Proceeds From Sales Property Plant Equipment-12 550-27 945   
Profit Loss-13 071 563-1 060 971-1 179 429-14 225 000-34 041 990
Profit Loss On Ordinary Activities Before Tax-13 965 867-2 083 086-2 184 224-16 983 432-37 881 458
Property Plant Equipment Gross Cost4 519 8254 213 048520 086105 927110 912
Purchase Property Plant Equipment-25 806-6 553-73 811-19 926-4 985
Share-based Payment Expense Cash Settled248 310367 365334 176665 521642 582
Social Security Costs223 106178 269224 622370 92340 288
Staff Costs Employee Benefits Expense2 349 3212 775 9532 697 4663 927 2823 313 798
Tax Expense Credit Applicable Tax Rate  -415 003-3 226 852-7 197 477
Tax Increase Decrease From Effect Different Tax Rates On Some Earnings-285125   
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss48 85169 98765 684126 734122 004
Tax Increase Decrease From Effect Unrelieved Tax Losses Carried Forward493 938449 769531 3431 007 8111 154 612
Tax Tax Credit On Profit Or Loss On Ordinary Activities-894 304-1 022 115-1 004 795-2 758 432-3 839 468
Total Assets Less Current Liabilities-1 408 950420 9071 173 6671 247 3902 009 125
Total Operating Lease Payments255 342241 631242 330312 192 
Trade Creditors Trade Payables2 115 318602 455364 8011 454 0882 012 253
Trade Debtors Trade Receivables    26 631
Wages Salaries2 079 0432 536 4682 395 2003 454 0113 171 680
Weighted Average Exercise Price Equity Instruments Exercisable Share-based Payment Arrangement14459179
Weighted Average Exercise Price Equity Instruments Exercised Share-based Payment Arrangement   3 
Weighted Average Exercise Price Equity Instruments Expired Share-based Payment Arrangement35370103
Weighted Average Exercise Price Equity Instruments Granted Share-based Payment Arrangement11333
Weighted Average Exercise Price Equity Instruments Outstanding Share-based Payment Arrangement621076
Company Contributions To Defined Benefit Plans Directors 22 12121 08321 98521 836
Director Remuneration 810 093811 821900 161905 569
Director Remuneration Benefits Including Payments To Third Parties 832 214832 904922 146927 405

Company filings

Filing category
Accounts Address Annual return Auditors Capital Change of name Confirmation statement Incorporation Miscellaneous Mortgage Officers Resolution
Full accounts data made up to Saturday 31st December 2022
filed on: 31st, August 2023 		Free Download (28 pages)

Company search

Companies nearby - by postcode

© bizstats.co.uk 2024.

Terms of Use and Privacy Policy
Contains public sector information licensed under the Open Government Licence v2.0.

Contact us

Email: info@bizstats.co.uk
All the information provided is derived from publicly available records. Unintentional errors are possible - bizstats.co.uk is not responsible for how accurate or up to date the data is. You use the information provided at your own risk.